Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07595432Recruiting

The Purpose of This Clinical Study is to Evaluate Optimized Maximum Plus for Maximum Visual Acuity (MPMVA) Refractive Technique and Its Effect on Visual Performance.

Role: lead

NCT00625313Not ApplicableCompleted

Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens

Role: lead

NCT01544777Not ApplicableCompleted

Visual Quality Following Aspheric Intraocular Lens (IOL) Implantation - a Comparative Clinical Study

Role: lead

NCT01292629Not ApplicableCompleted

Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.

Role: lead

NCT01268540Not ApplicableCompleted

Comparison of Aspheric Toric & Non-toric Aphakic Intraocular Lenses

Role: lead

All 5 trials loaded